BIRC5 and serous adenocarcinoma: In addition, we examined BIRC5 expression in ovarian cancer in the Oncomine database including 43 serous carcinomas and 10 peritoneal controls [27]; BIRC5 expression showed approximately a 20-fold increase in tumors compared to controls (P=5.68E-8) (Figure 1C).